Literature DB >> 1672430

Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?

G Klaus, O Mehls, J Hinderer, E Ritz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672430     DOI: 10.1016/0140-6736(91)91429-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Growth in children with chronic renal failure on intermittent versus daily calcitriol.

Authors:  Claus Peter Schmitt; Gianluigi Ardissino; Sara Testa; Aldo Claris-Appiani; Otto Mehls
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

2.  Alphacalcidol oral pulses normalize uremic hyperparathyroidism prior to dialysis.

Authors:  M Ala-Houhala; C Holmberg; K Rönnholm; A Paganus; J Laine; O Koskimies
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

3.  1.25(OH)2 cholecalciferol pulse therapy and the effects of different dialysis membranes on serum PTH levels of haemodialysis patients.

Authors:  M Boran; E Doruk; F Gönenç; S Cetin
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

Authors:  G Klaus; A Watson; A Edefonti; M Fischbach; K Rönnholm; F Schaefer; E Simkova; C J Stefanidis; V Strazdins; J Vande Walle; C Schröder; A Zurowska; M Ekim
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

Review 5.  Growth of prepubertal children on dialysis.

Authors:  Constantinos J Stefanidis; Günter Klaus
Journal:  Pediatr Nephrol       Date:  2007-03-31       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.